Xcout Intel
Spiral Therapeutics
Spiral Therapeutics Inc. is a clinical-stage pharmaceutical company based in South San Francisco, California, focused on delivering targeted therapies for inner ear conditions.
Subscribe to see Spiral Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Spiral Therapeutics at a glance
Spiral Therapeutics is a biotechnology company headquartered in United States. It has raised at least $46.4M across the 3 funding rounds on record. Its most recent funding round, Series B, raised $27M in April 2026. Xcout tracks 16 named people at Spiral Therapeutics, including Kyle Peterson (CHIEF FINANCIAL OFFICER).
Spiral Therapeutics leadership
- Kyle PetersonCHIEF FINANCIAL OFFICER
- Charles Limb, MDCHIEF MEDICAL OFFICER
- Eugene de Juan, MDEXECUTIVE CHAIRMAN
- Hugo PerisFOUNDER & CEO
- Jeffrey Sharon, MDSVP CLINICAL SCIENCE
- Eugene de Juan, MDExecutive Officer
10 more named people on record for Spiral Therapeutics, with roles, board committees and tenure — see the full roster →
Spiral Therapeutics funding rounds
At least $46.4M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $27M | 6 named | |
| SEC Form D filing | $10.9M | — | |
| SEC Form D filing | $8.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Spiral Therapeutics competitors
A few of Spiral Therapeutics's closest competitors — see the full list of competitors and alternatives →
Sensorion is a French biopharmaceutical company developing therapies for inner-ear disorders, including hearing loss and vestibular diseases. Its products are intended for patients with debilitating auditory and balance-related conditions, serving healthcare providers and the broader biopharmaceutical market.
Circle Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, harnessing macrocycles for drug development.
Switch Therapeutics Inc. is a biotechnology company headquartered in South San Francisco, California. Founded in 2020, the company develops RNAi therapies based on its proprietary technology.
Oricula Therapeutics LLC is a biotechnology company developing medications designed to prevent drug-induced hearing loss. Its lead product candidate, an oral medication called ORC-13661, aims to protect inner ear hair cells from the damaging side effects of aminoglycoside antibiotics.
Skylark Bio is a biotechnology company developing precision-targeted, locally delivered gene therapies to treat genetic hearing loss and other single-gene disorders. The company's platform aims to restore natural biological processes and hearing function, addressing conditions that affect children and individuals with genetic communication impairments.
Get Spiral Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Spiral Therapeutics in Xcout Intel
- 16 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access